Quantcast
Home / Opinion Digests / Settlement class certified in pharmaceutical antitrust case (access required)

Settlement class certified in pharmaceutical antitrust case (access required)

Although nonsettling defendants Glenmark and Merck objected to the certification of the settlement class on the basis that the court’s findings of fact and conclusions of law could prejudice them during their own class certification litigation, they could not demonstrate formal legal prejudice and thus the proposed settlement class was approved. Background This multidistrict antitrust litigation centers ...